1887

Abstract

Despite frequent use of immunosuppressive drugs in patients with inflammatory bowel disease (IBD) and reports of cytomegalovirus (CMV) infection following post-transplant immunosuppression, data on the frequency and clinical significance of CMV in patients with IBD are scant. Sixty-three patients with IBD (61 ulcerative colitis and two Crohn's disease) were evaluated for CMV using serology (IgM antibody, μ-capture ELISA), PCR for CMV DNA in colonic biopsy and histological assessment of haematoxylin and eosin-stained colonic biopsy. Positive result in any test was considered as CMV infection. Various parameters associated with CMV infection were analysed using univariate and multivariate analysis. Ten of 63 (15.8 %) patients (age 36.0 ± 11.2 years, 31 female) were infected with CMV (DNA alone in four, IgM antibody alone in two and both in four, inclusion body in one). Patients with CMV infection were more often female (8/10 vs 23/53, < 0.05), had pancolitis (10/10 vs 33/53, < 0.05), histological activity (9/10 vs 17/53, < 0.005) and used azathioprine (5/10 vs 7/53, = 0.04; Fisher exact test for all). On multivariate analysis, female gender, pancolitis and histological activity were the independent factors associated with infection. Patients with CMV infection more often required surgical treatment for IBD (4/10 vs 4/53, = 0.01) and had fatal outcome (3/10 vs 0/53, = 0.003). CMV infection in patients with IBD may be common and is associated with poor outcome. PCR of rectal biopsy was the most sensitive method of detection followed by IgM antibody for diagnosis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45629-0
2004-11-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/53/11/JM531117.html?itemId=/content/journal/jmm/10.1099/jmm.0.45629-0&mimeType=html&fmt=ahah

References

  1. Adani, G. L., Avital, I., Ferraresso, C. & Aoki, T. ( 2001;). CMV infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 96, 3464–3465.[CrossRef]
    [Google Scholar]
  2. Baron, J. H., Connell, A. M. & Lennard-Jones, J. E. ( 1964;). Variation between observers in describing mucosal appearance in proctocolitis. Br Med J 5375, 89–92.
    [Google Scholar]
  3. Beaugerie, L., Cywiner-Golenzer, C., Monfort, L. & 8 other authors ( 1997;). Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 14, 423–429.[CrossRef]
    [Google Scholar]
  4. Berk, T., Gordon, S. J., Choi, H. Y. & Cooper, H. S. ( 1985;). Cytomegalovirus of the colon: a possible role in exacerbation of inflammatory bowel disease. Am J Gastroenterol 80, 355–360.
    [Google Scholar]
  5. Bloomfeld, R. S. ( 2001;). Are we missing CMV infections in patients hospitalized with severe colitis? Inflamm Bowel Dis 7, 348–349.[CrossRef]
    [Google Scholar]
  6. Cooper, H. S., Raffensperger, E. C., Jonas, L. & Fitts, W. T., Jr ( 1977;). Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology 72, 1253–1256.
    [Google Scholar]
  7. Cottone, M., Pietrosi, G., Martorana, G. & 7 other authors ( 2001;). Prevalence of cytomegalovirus infection in severe refactory ulcerative and Crohn's colitis. Am J Gastroenterol 96, 773–775.[CrossRef]
    [Google Scholar]
  8. D'Haens, G., Suenaert, P., Westhovens, R. & Rutgeerts, P. ( 1998;). Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine. Inflamm Bowel Dis 4, 27–28.[CrossRef]
    [Google Scholar]
  9. Diepersloot, R. J. A., Kroes, A. C. M., Visser, W., Jiwa, N. M. & Rothbarth, P. H. ( 1990;). Acute ulcerative proctocolitis associated with primary cytomegalovirus infection. Arch Intern Med 50, 1749–1751.
    [Google Scholar]
  10. Eyre-Brook, I. A. & Dundas, S. ( 1986;). Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut 27, 1419–1425.[CrossRef]
    [Google Scholar]
  11. Goodgame, R. W. ( 1993;). Gastrointestinal cytomegalovirus disease. Ann Intern Med 119, 924–935.[CrossRef]
    [Google Scholar]
  12. Goodman, Z. D., Boitnott, J. K. & Yardley, J. H. ( 1979;). Perforation of the colon associated with cytomegalovirus infection. Dig Dis Sci 24, 376–380.[CrossRef]
    [Google Scholar]
  13. Harvey, R. F. & Bradshaw, M. J. ( 1980;). Measuring Crohn's disease activity. Lancet 1, 1134–1135.
    [Google Scholar]
  14. Hinnant, K. L., Rotterdam, H. Z., Bell, E. T. & Tapper, M. L. ( 1986;). Cytomegalovirus infection of the alimentary tract: a clinicopathological correlation. Am J Gastroenterol 81, 944–950.
    [Google Scholar]
  15. Kaufman, H. S., Kahn, A. C., Iacobuzio-Donahue, C., Talamini, M. A., Lillemoe, K. D. & Hamilton, S. R. ( 1999;). Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 42, 24–30.[CrossRef]
    [Google Scholar]
  16. Keren, D. F., Milligan, F. D., Strandberg, J. D. & Yardley, J. H. ( 1975;). Intermittent cytomegalovirus colitis in a patient with ulcerative colitis. Johns Hopkins Med J 136, 178–182.
    [Google Scholar]
  17. Kho, Y. H., Pool, M. O., Jansman, F. G. & Harting, J. W. ( 2001;). Pharmacotherapeutic options in inflammatory bowel disease: an update. Pharm World Sci 23, 17–21.[CrossRef]
    [Google Scholar]
  18. Kumar S., Ghoshal, U. C., Aggarwal, R., Saraswat, V. A. & Choudhuri, G. ( 2004;). Severe ulcerative colitis: a prospective study of parameters determining outcome. J Gastroenterol Hepatol (in press).
  19. Lortholary, O., Perrone, C. Leport, J., Leport, C. & Vilde, J. L. ( 1993;). Primary cytomegalovirus infection associated with the onset of ulcerative colitis. Eur J Clin Microbiol Infect Dis 12, 570–572.[CrossRef]
    [Google Scholar]
  20. Malhi, N. S., Bhasin, D. K., Gupta, N. M., Vaiphei, K. & Singh, K. ( 2003;). Exacerbation of ulcerative colitis by cytomegalovirus infection in an immunocompetent Indian patient. Trop Gastroenterol 23, 88–90.
    [Google Scholar]
  21. Marion, J. F. & Present, D. H. ( 1997;). The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol 9, 831–835.[CrossRef]
    [Google Scholar]
  22. Mendez, J. C., Espy, M. J., Smith, T. F., Wilson, J. A. & Paya, C. V. ( 1998;). Evaluation of PCR primers for early diagnosis of Cytomegalovirus infection following liver transplantation. J Clin Microbiol 36, 526–530.
    [Google Scholar]
  23. Ng, F. H., Chau, T. N., Cheung, T. C. & 7 other authors ( 1999;). Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci 44, 945–952.[CrossRef]
    [Google Scholar]
  24. Papadakis, K. A., Tung, J. K., Binder, S. W., Kam, L. Y., Abreu, M. T., Targan, S. R. & Vasiliauskas, E. A. ( 2001;). Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 96, 2137–2142.[CrossRef]
    [Google Scholar]
  25. Patel, R. & Paya, C. V. ( 1997;). Infections in solid-organ transplant recipients. Clin Microbiol Rev 10, 86–124.
    [Google Scholar]
  26. Paya, C. V., Holley, K. E., Wiesner, R. H. & 7 other authors ( 1990;). Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: role of immunostaining, DNA hybridization and culture of hepatic tissue. Hepatology 12, 119–126.[CrossRef]
    [Google Scholar]
  27. Pera, A., Bellando, P., Caldera, D. & 7 other authors ( 1987;). Colonoscopy in inflammatory bowel disease: diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 92, 181–185.
    [Google Scholar]
  28. Pfau, P., Kochman, M. L., Furth, E. E. & Lichtenstein, G. R. ( 2001;). Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naïve patient. Am J Gastroenterol 96, 895–899.[CrossRef]
    [Google Scholar]
  29. Powell, R. D., Warne, N. E., Levine, R. S. & Kirsner, J. B. ( 1961;). Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am J Med 30, 334–340.[CrossRef]
    [Google Scholar]
  30. Rahbar, A., Bostrom, L., Lagerstedt, U., Magnusson, I., Soderberg-Naucler, C. & Sundqvist, V. A. ( 2003;). Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis 9, 154–161.[CrossRef]
    [Google Scholar]
  31. Sia, I. G. & Patel, R. ( 2000;). New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 13, 83–121.[CrossRef]
    [Google Scholar]
  32. Soderberg-Naucler, C., Fish, K. N. & Nelson, J. A. ( 1997;). Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 100, 3154–3163.[CrossRef]
    [Google Scholar]
  33. Sood, A., Midha, V., Sood, N., Bhatia, A. S. & Avasthi, G. ( 2003;). Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 52, 1587–1590.[CrossRef]
    [Google Scholar]
  34. Storch, G. A., Buller, R. S., Bailey, T. C., Ettinger, N. A., Langlois, T., Gaudreault-Keener, M. & Welby, P. L. ( 1994;). Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Microbiol 32, 997–1003.
    [Google Scholar]
  35. Toogood, G. J., Gillespie, P. H., Gujral, S., Warren, B. F., Roake, J. A., Gray, D. W. & Morris, P. J. ( 1996;). Cytomegalovirus infection and colonic perforation in renal transplant patients. Transpl Int 9, 248–251.[CrossRef]
    [Google Scholar]
  36. Truelove, S. C. & Witts, L. J. ( 1955;). Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 4947, 1041–1048.
    [Google Scholar]
  37. Truelove, S. C. & Richards, W. C. ( 1956;). Biopsy studies in ulcerative colitis. Br Med J 4979, 1315–1318.
    [Google Scholar]
  38. Vega, R., Bertran, X., Menacho, M., Domenech, E., Moreno de Vega, V., Hombrados, M., Cabre, E. Ojanguren, I. & Gassull, M. A. ( 1999;). Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 94, 1053–1056.[CrossRef]
    [Google Scholar]
  39. Waya, Y., Matsui, T., Mataki, H. & 9 other authors ( 2003;). Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis and treatment. Dis Colon Rectum 46, S59–S65.[CrossRef]
    [Google Scholar]
  40. Whitley, R. J., Jacobson, M. A., Friedberg, D. N. & 14 other authors ( 1998;). Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel.International AIDS Society-USA. Arch Intern Med 158, 957–969.[CrossRef]
    [Google Scholar]
  41. Wiesner, R. H., Marin, E., Porayko, M. K., Steers, J. L., Krom, R. A. F. & Paya, C. V. ( 1993;). Advances in the diagnosis, treatment and prevention of cytomegalovirus infections after liver transplantation. Gastroenterol Clin North Am 22, 351–366.
    [Google Scholar]
  42. Yakushiji, K., Gondo, H., Kamezaki, K. & 16 other authors ( 2002;). Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant 29, 599–606.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45629-0
Loading
/content/journal/jmm/10.1099/jmm.0.45629-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error